| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dendritic Cells | 11 | 2014 | 1085 | 1.240 |
Why?
|
| Thyroglobulin | 6 | 2007 | 62 | 1.050 |
Why?
|
| Thyroiditis, Autoimmune | 4 | 2007 | 36 | 0.710 |
Why?
|
| Myocarditis | 3 | 2008 | 190 | 0.610 |
Why?
|
| Multiple Myeloma | 14 | 2014 | 2138 | 0.570 |
Why?
|
| Autoimmune Diseases | 3 | 2008 | 402 | 0.560 |
Why?
|
| Osteoclasts | 3 | 2013 | 165 | 0.550 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2016 | 31 | 0.540 |
Why?
|
| GATA2 Transcription Factor | 1 | 2016 | 68 | 0.530 |
Why?
|
| Zinc Fingers | 1 | 2016 | 205 | 0.510 |
Why?
|
| Bone Marrow Diseases | 1 | 2016 | 177 | 0.500 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 280 | 0.500 |
Why?
|
| Anemia, Aplastic | 1 | 2016 | 214 | 0.490 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2016 | 479 | 0.470 |
Why?
|
| Bone Marrow Cells | 4 | 2016 | 943 | 0.440 |
Why?
|
| Interferon Regulatory Factors | 1 | 2012 | 76 | 0.430 |
Why?
|
| Sequence Deletion | 1 | 2016 | 875 | 0.430 |
Why?
|
| Iodine | 3 | 2007 | 54 | 0.410 |
Why?
|
| Peyer's Patches | 1 | 2011 | 30 | 0.410 |
Why?
|
| Immune Tolerance | 3 | 2013 | 403 | 0.400 |
Why?
|
| Mice | 35 | 2016 | 34495 | 0.390 |
Why?
|
| Bone and Bones | 2 | 2016 | 619 | 0.390 |
Why?
|
| STAT1 Transcription Factor | 1 | 2011 | 156 | 0.380 |
Why?
|
| Autoantigens | 3 | 2007 | 234 | 0.370 |
Why?
|
| Receptor Cross-Talk | 1 | 2010 | 79 | 0.360 |
Why?
|
| RNA, Messenger | 3 | 2012 | 6150 | 0.360 |
Why?
|
| Thyroid Gland | 3 | 2007 | 355 | 0.350 |
Why?
|
| Interleukin-9 | 3 | 2014 | 37 | 0.350 |
Why?
|
| Lymphocyte Activation | 5 | 2010 | 1688 | 0.340 |
Why?
|
| Bone Marrow | 3 | 2016 | 2358 | 0.340 |
Why?
|
| Cell Differentiation | 10 | 2014 | 4078 | 0.340 |
Why?
|
| Antigen-Presenting Cells | 1 | 2010 | 284 | 0.330 |
Why?
|
| CD8-Positive T-Lymphocytes | 6 | 2014 | 1586 | 0.320 |
Why?
|
| Immune System | 1 | 2010 | 279 | 0.320 |
Why?
|
| Interferon-alpha | 2 | 2011 | 889 | 0.310 |
Why?
|
| Sodium Iodide | 1 | 2007 | 1 | 0.300 |
Why?
|
| Monoiodotyrosine | 1 | 2007 | 1 | 0.300 |
Why?
|
| Melanoma, Experimental | 3 | 2014 | 368 | 0.300 |
Why?
|
| Goiter | 1 | 2007 | 17 | 0.300 |
Why?
|
| Lymphocytes | 2 | 2008 | 1234 | 0.280 |
Why?
|
| Animals | 36 | 2016 | 59536 | 0.280 |
Why?
|
| Antigens | 1 | 2006 | 292 | 0.260 |
Why?
|
| Disease Models, Animal | 7 | 2016 | 7222 | 0.260 |
Why?
|
| Hypothyroidism | 1 | 2007 | 204 | 0.260 |
Why?
|
| Mice, Inbred CBA | 5 | 2007 | 78 | 0.250 |
Why?
|
| Tyrosine | 1 | 2006 | 498 | 0.250 |
Why?
|
| Epitopes | 1 | 2007 | 685 | 0.250 |
Why?
|
| CD4-Positive T-Lymphocytes | 6 | 2014 | 1033 | 0.250 |
Why?
|
| Thymus Gland | 1 | 2005 | 294 | 0.230 |
Why?
|
| Immunophenotyping | 4 | 2016 | 1681 | 0.230 |
Why?
|
| Bone Marrow Transplantation | 1 | 2008 | 1581 | 0.220 |
Why?
|
| Lymphoma, Mantle-Cell | 3 | 2013 | 713 | 0.220 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2014 | 212 | 0.210 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2014 | 1489 | 0.210 |
Why?
|
| beta 2-Microglobulin | 2 | 2014 | 184 | 0.210 |
Why?
|
| Cancer Vaccines | 3 | 2012 | 697 | 0.210 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 1450 | 0.210 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2012 | 408 | 0.200 |
Why?
|
| Mice, SCID | 10 | 2014 | 1869 | 0.200 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2012 | 334 | 0.190 |
Why?
|
| Peptides | 1 | 2007 | 1479 | 0.190 |
Why?
|
| Major Histocompatibility Complex | 3 | 2010 | 91 | 0.190 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2012 | 203 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 8 | 2014 | 6942 | 0.170 |
Why?
|
| MicroRNAs | 1 | 2012 | 2947 | 0.170 |
Why?
|
| Diet | 1 | 2007 | 1440 | 0.170 |
Why?
|
| Apoptosis | 8 | 2014 | 7591 | 0.160 |
Why?
|
| Cell Lineage | 2 | 2012 | 668 | 0.150 |
Why?
|
| B-Lymphocytes | 4 | 2012 | 1294 | 0.150 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2016 | 1242 | 0.150 |
Why?
|
| B7-H1 Antigen | 2 | 2014 | 1022 | 0.140 |
Why?
|
| Coculture Techniques | 4 | 2014 | 626 | 0.140 |
Why?
|
| Decalcification, Pathologic | 1 | 2016 | 7 | 0.140 |
Why?
|
| Cytokines | 5 | 2014 | 2809 | 0.140 |
Why?
|
| Side-Population Cells | 1 | 2016 | 18 | 0.140 |
Why?
|
| Immunotherapy, Adoptive | 3 | 2014 | 1763 | 0.140 |
Why?
|
| Antigens, Neoplasm | 3 | 2012 | 1506 | 0.130 |
Why?
|
| Interferon-gamma | 3 | 2014 | 1144 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 4 | 2014 | 4367 | 0.130 |
Why?
|
| Gene Expression Regulation | 4 | 2016 | 4053 | 0.130 |
Why?
|
| Macrophages | 2 | 2012 | 1304 | 0.120 |
Why?
|
| Gene Expression | 3 | 2016 | 3570 | 0.120 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 518 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2014 | 8873 | 0.120 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2014 | 84 | 0.120 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2013 | 46 | 0.120 |
Why?
|
| Interleukin-6 | 3 | 2014 | 1038 | 0.120 |
Why?
|
| Immunity, Cellular | 2 | 2012 | 419 | 0.120 |
Why?
|
| Genes, Reporter | 1 | 2016 | 798 | 0.120 |
Why?
|
| Islets of Langerhans | 1 | 2014 | 229 | 0.120 |
Why?
|
| STAT3 Transcription Factor | 2 | 2010 | 1121 | 0.110 |
Why?
|
| Adoptive Transfer | 2 | 2006 | 446 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 7 | 2014 | 5395 | 0.110 |
Why?
|
| Chemokine CCL2 | 1 | 2013 | 203 | 0.110 |
Why?
|
| Antigen Presentation | 2 | 2012 | 272 | 0.110 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2014 | 216 | 0.110 |
Why?
|
| CD11c Antigen | 1 | 2012 | 55 | 0.110 |
Why?
|
| Gene Frequency | 1 | 2016 | 1163 | 0.110 |
Why?
|
| CD11b Antigen | 1 | 2012 | 66 | 0.110 |
Why?
|
| Hematopoiesis | 1 | 2016 | 560 | 0.110 |
Why?
|
| CD18 Antigens | 1 | 2012 | 83 | 0.110 |
Why?
|
| Leukocyte Common Antigens | 1 | 2012 | 188 | 0.110 |
Why?
|
| P-Selectin | 1 | 2012 | 124 | 0.110 |
Why?
|
| T-Lymphocytes | 3 | 2013 | 3869 | 0.110 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2012 | 221 | 0.100 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2011 | 23 | 0.100 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 1 | 2011 | 17 | 0.100 |
Why?
|
| Bone Resorption | 1 | 2012 | 138 | 0.100 |
Why?
|
| Osteolysis | 1 | 2012 | 80 | 0.100 |
Why?
|
| Peptide Fragments | 3 | 2007 | 1271 | 0.100 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 343 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2012 | 3639 | 0.100 |
Why?
|
| Tumor Escape | 1 | 2013 | 251 | 0.100 |
Why?
|
| Vaccines, DNA | 1 | 2011 | 105 | 0.100 |
Why?
|
| Bone Diseases | 1 | 2012 | 143 | 0.100 |
Why?
|
| STAT5 Transcription Factor | 1 | 2012 | 214 | 0.100 |
Why?
|
| Leukopoiesis | 1 | 2010 | 7 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 622 | 0.100 |
Why?
|
| Mice, Knockout | 3 | 2016 | 5710 | 0.090 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 2014 | 1016 | 0.090 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2010 | 88 | 0.090 |
Why?
|
| Osteoblasts | 1 | 2012 | 370 | 0.090 |
Why?
|
| Chemokine CXCL2 | 1 | 2010 | 35 | 0.090 |
Why?
|
| Morpholines | 1 | 2011 | 289 | 0.090 |
Why?
|
| Aminopyridines | 1 | 2011 | 212 | 0.090 |
Why?
|
| Immunoglobulin M | 1 | 2011 | 347 | 0.090 |
Why?
|
| Th17 Cells | 1 | 2011 | 162 | 0.090 |
Why?
|
| Cell Proliferation | 8 | 2014 | 7226 | 0.090 |
Why?
|
| Granulocytes | 1 | 2010 | 224 | 0.090 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2010 | 157 | 0.090 |
Why?
|
| Mice, Inbred ICR | 2 | 2007 | 239 | 0.090 |
Why?
|
| Immunologic Memory | 1 | 2011 | 374 | 0.090 |
Why?
|
| Dexamethasone | 2 | 2011 | 1450 | 0.090 |
Why?
|
| Chromosomes, Mammalian | 1 | 2008 | 59 | 0.080 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2007 | 219 | 0.080 |
Why?
|
| Cardiac Myosins | 1 | 2008 | 18 | 0.080 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2011 | 582 | 0.080 |
Why?
|
| Interleukin-10 | 4 | 2013 | 478 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 650 | 0.080 |
Why?
|
| HLA-A2 Antigen | 1 | 2009 | 159 | 0.080 |
Why?
|
| Tumor Microenvironment | 3 | 2014 | 2864 | 0.080 |
Why?
|
| Adjuvants, Immunologic | 1 | 2011 | 657 | 0.080 |
Why?
|
| Carcinogenesis | 1 | 2014 | 1026 | 0.080 |
Why?
|
| Membrane Glycoproteins | 1 | 2012 | 1073 | 0.080 |
Why?
|
| Genotype | 1 | 2016 | 4109 | 0.080 |
Why?
|
| Thyroiditis | 1 | 2007 | 18 | 0.080 |
Why?
|
| Th2 Cells | 1 | 2008 | 257 | 0.080 |
Why?
|
| Th1 Cells | 1 | 2008 | 250 | 0.070 |
Why?
|
| Histocompatibility Antigens | 1 | 2007 | 74 | 0.070 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2010 | 749 | 0.070 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 634 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 1491 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2014 | 830 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 2291 | 0.070 |
Why?
|
| Signal Transduction | 7 | 2014 | 11965 | 0.070 |
Why?
|
| Thyroid Hormones | 1 | 2007 | 111 | 0.070 |
Why?
|
| Histocompatibility Antigens Class I | 3 | 2014 | 235 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 521 | 0.070 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2011 | 801 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2011 | 673 | 0.070 |
Why?
|
| Blotting, Western | 4 | 2012 | 3536 | 0.070 |
Why?
|
| Neutrophils | 1 | 2010 | 835 | 0.070 |
Why?
|
| Cell Survival | 4 | 2014 | 3045 | 0.070 |
Why?
|
| Mice, Inbred NOD | 3 | 2014 | 905 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 3 | 2012 | 1165 | 0.060 |
Why?
|
| Interleukin-12 | 1 | 2006 | 253 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2008 | 5539 | 0.060 |
Why?
|
| Necrosis | 1 | 2006 | 580 | 0.060 |
Why?
|
| Autoimmunity | 1 | 2006 | 263 | 0.060 |
Why?
|
| Stem Cells | 1 | 2011 | 1213 | 0.060 |
Why?
|
| Cell Line, Tumor | 7 | 2012 | 14551 | 0.060 |
Why?
|
| Biomarkers | 1 | 2016 | 5047 | 0.060 |
Why?
|
| Cell Communication | 3 | 2014 | 509 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 3154 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2007 | 4233 | 0.060 |
Why?
|
| Antibodies | 1 | 2006 | 838 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2005 | 842 | 0.050 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 2216 | 0.050 |
Why?
|
| Immunoglobulin Idiotypes | 2 | 2012 | 51 | 0.050 |
Why?
|
| Humans | 18 | 2014 | 261506 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 1021 | 0.050 |
Why?
|
| Up-Regulation | 3 | 2013 | 2450 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 6089 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 3230 | 0.050 |
Why?
|
| Myocardium | 1 | 2008 | 1313 | 0.050 |
Why?
|
| Female | 10 | 2014 | 141928 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2012 | 5178 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2012 | 5270 | 0.050 |
Why?
|
| Flow Cytometry | 3 | 2012 | 3033 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2006 | 5637 | 0.050 |
Why?
|
| Immunoprecipitation | 2 | 2012 | 591 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2014 | 675 | 0.040 |
Why?
|
| Lipopolysaccharides | 2 | 2012 | 558 | 0.040 |
Why?
|
| Protein Binding | 1 | 2006 | 3438 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 2 | 2014 | 778 | 0.040 |
Why?
|
| Melphalan | 2 | 2012 | 834 | 0.040 |
Why?
|
| Stromal Cells | 2 | 2013 | 825 | 0.040 |
Why?
|
| Prognosis | 1 | 2016 | 21713 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 4654 | 0.040 |
Why?
|
| Antineoplastic Agents, Alkylating | 2 | 2012 | 588 | 0.040 |
Why?
|
| Kidney | 1 | 2005 | 2146 | 0.030 |
Why?
|
| Melanoma | 1 | 2012 | 5317 | 0.030 |
Why?
|
| Vaccination | 2 | 2011 | 1123 | 0.030 |
Why?
|
| Liver | 1 | 2005 | 2961 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 5159 | 0.030 |
Why?
|
| Immunotherapy | 3 | 2012 | 3341 | 0.030 |
Why?
|
| Male | 8 | 2014 | 123000 | 0.030 |
Why?
|
| Interleukin-3 | 1 | 2014 | 96 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2014 | 3821 | 0.030 |
Why?
|
| Complement System Proteins | 1 | 2014 | 139 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 2014 | 295 | 0.030 |
Why?
|
| Receptors, CCR6 | 1 | 2012 | 22 | 0.030 |
Why?
|
| Chemokine CCL20 | 1 | 2012 | 39 | 0.030 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 1 | 2012 | 17 | 0.030 |
Why?
|
| Spleen | 1 | 2014 | 676 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2012 | 86 | 0.030 |
Why?
|
| Immune Evasion | 1 | 2012 | 73 | 0.030 |
Why?
|
| Receptors, OX40 | 1 | 2011 | 50 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2012 | 174 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 155 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2011 | 182 | 0.020 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2011 | 62 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2011 | 162 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2011 | 261 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2011 | 80 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 1519 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 503 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2011 | 264 | 0.020 |
Why?
|
| Receptors, Interleukin-8 | 1 | 2010 | 6 | 0.020 |
Why?
|
| Thalidomide | 1 | 2014 | 569 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2011 | 342 | 0.020 |
Why?
|
| Listeria monocytogenes | 1 | 2010 | 52 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2010 | 62 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2010 | 132 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2011 | 309 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2014 | 649 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 191 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 11538 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2014 | 677 | 0.020 |
Why?
|
| Monocytes | 1 | 2013 | 788 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2009 | 134 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 1077 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 703 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 1408 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 14289 | 0.020 |
Why?
|
| Myosins | 1 | 2008 | 96 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 1217 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2011 | 1313 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 886 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 639 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2008 | 182 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 612 | 0.020 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2014 | 1048 | 0.020 |
Why?
|
| Hybridomas | 1 | 2007 | 75 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 2314 | 0.020 |
Why?
|
| Immunization | 1 | 2008 | 397 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2014 | 3001 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 848 | 0.020 |
Why?
|
| Cell Death | 1 | 2008 | 671 | 0.020 |
Why?
|
| Caspases | 1 | 2008 | 661 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 461 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 1533 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 1678 | 0.020 |
Why?
|
| Clone Cells | 1 | 2007 | 555 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2010 | 810 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2012 | 1549 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2005 | 186 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 1764 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2010 | 2084 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2009 | 1385 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 3101 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2012 | 6100 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 4143 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 2330 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 6295 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2007 | 2967 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 32848 | 0.010 |
Why?
|